Through GESA, we noted that the high expression of PCSK6 was correlated with the up-regulation of the Kras signaling pathway compared to the low expression of PCSK6 in the cell lines of pancreatic cancer (Figure 8A,B). This evidence concerns the gene KRAS and pancreatic neoplasm.